{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,5]],"date-time":"2025-05-05T04:02:54Z","timestamp":1746417774110,"version":"3.40.4"},"reference-count":19,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"11","license":[{"start":{"date-parts":[[2021,3,19]],"date-time":"2021-03-19T00:00:00Z","timestamp":1616112000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Rationale:<\/jats:title>\n            <jats:p>Primary pulmonary lymphoepithelioma-like carcinoma (PPLELC) is a rare subtype of non-small cell lung cancer (NSCLC). It is predominantly reported in East Asia and currently there is no standard treatment for this disease. We report a case of stage IV PPLELC that achieved pathological complete response (pCR) by neoadjuvant treatment.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Patient concerns:<\/jats:title>\n            <jats:p>The patient was a 46-year-old male who developed hemoptysis for about 20\u200aml of volume accompanied by cough and sputum after physical labor.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Diagnoses:<\/jats:title>\n            <jats:p>Contrast enhanced chest CT scanning showed occupation of left lower hilar area and left pleural effusion. Combined with medical history and auxiliary examination, the patient was formally diagnosed stage IV lymphoepithelioma-like carcinoma of the left lower lung (T3N0M1a pleura).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Interventions:<\/jats:title>\n            <jats:p>The patient was given Sintilimab combined with gemcitabine + nedaplatin chemotherapy (GP) regimen for four cycles with 3\u200aweeks as a cycle, supplemented with antiemetics and stomach protection drugs to reduce chemotherapy-related side effects.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Outcomes:<\/jats:title>\n            <jats:p>After 4 cycles of treatment, the patient's left lung lesion has been markedly reduced and the left pleural effusion has also been significantly absorbed. Remarkably, surgical biopsies found no cancer cells in the lesion site and postoperative pathology showed complete pathological remission (pCR).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Lessons:<\/jats:title>\n            <jats:p>We reported a case of PPLELC that is sensitive to neoadjuvant treatment, showing excellent effectiveness and safety and achieving pCR.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000024987","type":"journal-article","created":{"date-parts":[[2021,3,16]],"date-time":"2021-03-16T22:09:33Z","timestamp":1615932573000},"page":"e24987","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":3,"title":["Primary pulmonary lymphoepithelioma-like carcinoma"],"prefix":"10.1097","volume":"100","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1623-7881","authenticated-orcid":false,"given":"Liqin","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tairan","family":"Hao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuqing","family":"Wei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mo","family":"Dong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuancheng","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2021,3,19]]},"reference":[{"key":"R1-20250504","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1002\/jso.2930360413","article-title":"Epstein-barr virus related lymphoepithelioma-like carcinoma of lung","volume":"36","author":"B\u00e9gin","year":"1987","journal-title":"J Surg Oncol"},{"key":"R2-20250504","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1309\/148K-ND54-6NJX-NA61","article-title":"Association of Epstein-Barr virus with lymphoepithelioma-like carcinoma of the lung in southern China","volume":"114","author":"Han","year":"2000","journal-title":"Am J Clin Pathol"},{"key":"R3-20250504","doi-asserted-by":"crossref","first-page":"4748","DOI":"10.1002\/cncr.27452","article-title":"Primary lymphoepithelioma-like carcinoma: fifty-two patients with long-term follow up","volume":"118","author":"Liang","year":"2012","journal-title":"Cancer"},{"key":"R4-20250504","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1053\/hupa.2001.26457","article-title":"Relationship between Epstein-Barr virus and lymphoepithelioma-like carcinoma of the lung: a clinicopathologic study of 6 cases and review of the literature","volume":"32","author":"Castro","year":"2001","journal-title":"Hum Pathol"},{"key":"R5-20250504","first-page":"60","article-title":"CT features of primary pulmonary lymphoepithelioma-like carcinoma: report of 14 cases and literature review","volume":"14","author":"Bao","year":"2016","journal-title":"Chin J CT MRI"},{"key":"R6-20250504","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.cllc.2012.01.002","article-title":"Multimodality treatment and long-term follow-up of the primary pulmonary lymphoepithelioma-like carcinoma","volume":"13","author":"Huang","year":"2012","journal-title":"Clin Lung Cancer"},{"key":"R7-20250504","doi-asserted-by":"crossref","first-page":"3108","DOI":"10.1038\/s41467-019-10902-w","article-title":"The genomic landscape of Epstein-Barr virus-associated pulmonary lymphoepithelioma-like carcinoma","volume":"10","author":"Hong","year":"2019","journal-title":"Nat Commun"},{"key":"R8-20250504","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.lungcan.2019.09.007","article-title":"First-line platinum-based chemotherapy and survival outcomes in locally advanced or metastatic pulmonary lymphoepithelioma-like carcinoma","volume":"137","author":"Lin","year":"2019","journal-title":"Lung Cancer"},{"key":"R9-20250504","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1111\/1759-7714.12060","article-title":"Lack of epidermal growth factor receptor gene mutations in exons 19 and 21 in primary lymphoepithelioma-like carcinoma of the lung","volume":"5","author":"Liu","year":"2014","journal-title":"Thorac Cancer"},{"key":"R10-20250504","first-page":"1556","article-title":"Detection of rearrangement of anaplastic lymphorna kinase (ALK) and mutation of epidermal growth factor receptor (EGFR) in primary pulmonary lymphoepithelioma-like carcinoma","volume":"7","author":"Wang","year":"2015","journal-title":"J Thorac Dis"},{"key":"R11-20250504","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1111\/1759-7714.13271","article-title":"Low Frequency of Mutation of Epidermal Growth Factor Receptor (EGFR) and Arrangement of Anaplastic Lymphoma Kinase (ALK) in primary pulmonary lymphoepithelioma-like carcinoma","volume":"11","author":"Yin","year":"2020","journal-title":"Thoracic Cancer"},{"key":"R12-20250504","doi-asserted-by":"crossref","first-page":"153043","DOI":"10.1016\/j.prp.2020.153043","article-title":"Primary pulmonary lymphoepithelioma-like carcinoma is characterized by high PD-L1 expression, but low tumor mutation burden","volume":"216","author":"Wu","year":"2020","journal-title":"Pathol Res Pract"},{"key":"R13-20250504","first-page":"25","article-title":"Expression of PD-1 and PD-L1 in primary pulmonary lymphoepithelioma-like carcinoma and their clinical significance","volume":"11","author":"Zhang","year":"2017","journal-title":"Chin J Mod Drug Appl"},{"key":"R14-20250504","first-page":"1451","article-title":"Positive expression of programmed death ligand-1 correlates with superior outcomes and might be a therapeutic target in primary pulmonary lymphoopithelioma-like carcinoma","volume":"8","author":"Jiang","year":"2015","journal-title":"Onco Targets Ther"},{"key":"R15-20250504","first-page":"168","article-title":"Clinical analysis of primary pulmonary lymphoepithelioma-like carcinoma in 8 patients","volume":"23","author":"Zhao","year":"2020","journal-title":"Chin J Lung Cancer"},{"key":"R16-20250504","doi-asserted-by":"crossref","first-page":"e238","DOI":"10.1016\/j.cllc.2018.12.015","article-title":"EBV-positive primary pulmonary lymphoepithelioma-like carcinoma response to PD-L1 blockade","volume":"20","author":"Narayanan","year":"2019","journal-title":"Clin Lung Cancer"},{"key":"R17-20250504","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.lungcan.2020.06.027","article-title":"Overcoming resistance to anti-PD-1 immunotherapy in lymphoepithelioma-like carcinoma: A case report and review of the literature","volume":"146","author":"Tang","year":"2020","journal-title":"Lung Cancer"},{"key":"R18-20250504","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1016\/j.jtho.2020.07.014","article-title":"Efficacy and safety of sintilimab plus pemetrexed and platinum as first-line treatment for locally advanced or metastatic nonsquamous non-small cell lung cancer: a randomized, double-blind, phase 3 study (ORIENT-11)","volume":"15","author":"Yang","year":"2020","journal-title":"J Thorac Oncol"},{"issue":"(15_suppl)","key":"R19-20250504","doi-asserted-by":"crossref","first-page":"8509","DOI":"10.1200\/JCO.2019.37.15_suppl.8509","article-title":"Neoadjuvant chemo-immunotherapy for the treatment of stage IIIA resectable non-small-cell lung cancer (NSCLC): a phase II multicenter exploratory study\u2014Final data of patients who underwent surgical assessment","volume":"37","author":"Provencio","year":"2019","journal-title":"J Clin Oncol"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000024987","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T06:29:48Z","timestamp":1746340188000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000024987"}},"subtitle":["A case report of pathological complete response (pCR) by neoadjuvant treatment"],"short-title":[],"issued":{"date-parts":[[2021,3,19]]},"references-count":19,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000024987","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"type":"print","value":"0025-7974"},{"type":"electronic","value":"1536-5964"}],"subject":[],"published":{"date-parts":[[2021,3,19]]},"assertion":[{"value":"2020-12-01","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-02-11","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}